Global Pet & Vet Supply Market Overview
The global pet care market, which includes pet & vet supply, was valued at over $320 billion in 2023 and is projected to grow at a compound annual growth rate above 7% through the next five years, driven by rising pet ownership and premiumization of products. The U.S. remains the largest national market, accounting for more than 30% of global revenue, with pet food, flea and tick prevention, and diagnostic supplies forming the core of the pet & vet supply category. According to industry analyses, the pet & vet supply segment specifically, covering pharmaceuticals, biologics, and medical devices for animal health, is expanding faster than general pet food, with an estimated value of over $30 billion in 2023 and a forecast to exceed $45 billion by the end of the decade Forbes.
Key demand drivers include the humanization of pets, increased spending on preventive care, and the expansion of veterinary services in emerging markets. In the U.S., approximately 70% of households own a pet, and average annual expenditure per household on pet products and services has risen steadily, with a growing share directed toward health-related supplies. Veterinary practices are increasingly stocking high-margin consumables such as vaccines, dental products, and diagnostic kits, which form a significant portion of the pet & vet supply chain. Regulatory oversight remains fragmented, with the FDA Center for Veterinary Medicine and the USDA Center for Veterinary Biologics jointly governing product approval and licensing, a structure that influences which companies can enter and scale within the pet & vet supply space FDA.
Leading Companies and Competitive Landscape
Top Pet & Vet Supply Manufacturers
The pet & vet supply sector is dominated by a mix of large animal health conglomerates and specialized pharmaceutical firms. Zoetis, a spinoff from Pfizer, is the world's largest animal health company by revenue, generating over $8 billion in annual sales and holding a dominant position in vaccines, parasiticides, and diagnostic imaging equipment for both companion animals and livestock. Elanco Animal Health, spun off from Eli Lilly, and Merck Animal Health are the next tier of major players, together controlling a substantial share of the global pet & vet supply market for pharmaceuticals and feed additives. In the veterinary devices and consumables segment, companies such as Covetrus and Heska provide distribution and diagnostic tools to clinics, forming the backbone of the pet & vet supply infrastructure in North America SEC Filings.
Private equity activity has intensified in the pet & vet supply space, with firms such as Clayton, Dubilier & Rice and JAB Holding Company acquiring veterinary distribution and services platforms. Covetrus, a joint venture between Henry Schein and Vets First Choice, serves as a major distributor of pet & vet supply products to independent practices, processing billions in transactions annually. Online-first competitors have also gained traction, with Chewy and PetMed Express capturing significant share of the direct-to-consumer prescription and wellness supply segment. The competitive landscape is shifting as large corporations consolidate distribution networks and invest in proprietary software for inventory management and client communication, raising barriers for smaller regional distributors Forbes.
